MedPath

Implantation of Bone Marrow Cells to Treat Avascular Necrosis of Femoral Head (ANFH)

Phase 2
Conditions
Avascular Necrosis of Femur Head
Registration Number
NCT01613612
Lead Sponsor
Guangdong Provincial People's Hospital
Brief Summary

The purpose of this study is to compare the efficacy of autologous enriched bone marrow cell implantation combined with core decompression to single core decompression for the treatment of avascular necrosis of femoral head.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • femoral head necrosis patients
  • stage I/II/III (Ficat)
  • age from 18 to 55 years
  • stop steroid treatment for minimal 6 months
Exclusion Criteria
  • age younger than 18 or older than 55
  • any hemopathy
  • tumor
  • femoral head/neck fracture

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
change of Visual Analogue Scalebefore invention and 24 months after invention

Change from baseline in 24 months

change of lequensne algofunctional indexbefore invention and 24 months after invention

change from baseline in 24 months

change of WOMAC indexbefore invention and 24 months after invention

change from baseline in 24 months

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.